Biovail Chairman Eugene Melnyk Announces Retirement.Sets June 30, 2007 as Retirement Date - 20(th) Anniversary of Public Listing of Company; Melnyk to Deliver Keynote Speech keynote speech n. See keynote address. Noun 1. keynote speech - a speech setting forth the keynote keynote address keynote - the principal theme in a speech or literary work at AGM AGM annual general meeting AGM n abbr (= annual general meeting) → AG f AGM n abbr (= annual general meeting) → JHV f Today TORONTO -- Biovail Corporation (NYSE NYSE See: New York Stock Exchange , TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension : BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency ) announced today that Chairman Eugene Melnyk informed the Board of Directors of Biovail last night that he will retire from the Company on June 30, 2007 - the 20th anniversary of publicly listing the Company on the Toronto Stock Exchange Toronto Stock Exchange (TSE) Canada's largest stock exchange, trading approximately 1,200 company stocks and 33 options. and becoming Chairman and Chief Executive Officer. Mr. Melnyk told the Board of Directors that this is a decision he has made over the last several months, and that he planned to formally make the announcement at the Company's annual general meeting in Toronto today. "The Company has grown tremendously under Mr. Melnyk's leadership over the past 25 years," says Biovail Chief Executive Officer Dr. Douglas Squires. "Today, we have more than 1,500 employees developing and supporting new innovative products. In 2006, for the first time in history, our annual revenues exceeded $1 billion." Mr. Melnyk was instrumental in growing the Company into one of the world's leading specialty pharmaceutical companies, engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products, utilizing advanced drug-delivery technologies. "Eugene's contribution to Biovail is immeasurable and we understand that this was not an easy decision," concluded Dr. Squires. "We fully respect and understand his desire to spend more time with his young family, and his desire to dedicate more time and energy to his contributions in education, childhood development, healthcare and sport." Mr. Melnyk will be delivering a keynote speech at Biovail's Annual and Special Meeting of Shareholders this morning at 10 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT in the Austin Gallery of the Dominion Club, 1 King Street W. in Toronto. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com. For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion